Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a “real world” studyMathias Jachs, Péter Ferenci, Albert Friedrich Stättermayer et al.|Alimentary Pharmacology & Therapeutics|2022Cited by 73
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal HypertensionKatharina Wöran, Bernhard Scheiner, Georg Semmler et al.|Clinical Gastroenterology and Hepatology|2020Cited by 68
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosisMathias Jachs, Thomas Reiberger, Teresa Binter et al.|United European Gastroenterology Journal|2021Cited by 32
COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related MortalityLukas Hartl, Bernhard Scheiner, Georg Semmler et al.|Hepatology Communications|2021Cited by 27